Alerts will be sent to your verified email
Verify EmailAPPL
|
Aptus Pharma
|
Zota Health Care
|
Sunrest Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
36.58 % | 1.99 % | 38.0 % |
|
5yr average Equity Multiplier
|
5.05 | 1.84 | 5.71 |
|
5yr Average Asset Turnover Ratio
|
1.72 | 0.91 | 1.32 |
|
5yr Avg Net Profit Margin
|
6.16 % | -4.95 % | 4.49 % |
|
Price to Book
|
0.0 | 6.94 | 0.0 |
|
P/E
|
87.29 | 0.0 | 7.31 |
|
5yr Avg Cash Conversion Cycle
|
88.73 Days | 40.5 Days | 85.25 Days |
|
Inventory Days
|
64.83 Days | 91.82 Days | 58.22 Days |
|
Days Receivable
|
65.8 Days | 42.2 Days | 397.25 Days |
|
Days Payable
|
77.01 Days | 92.36 Days | 220.86 Days |
|
5yr Average Interest Coverage Ratio
|
6.23 | 5.98 | 26.66 |
|
5yr Avg ROCE
|
28.46 % | -2.72 % | 24.04 % |
|
5yr Avg Operating Profit Margin
|
10.95 % | 3.69 % | 7.01 % |
|
5 yr average Debt to Equity
|
2.26 | 0.04 | 1.22 |
|
5yr CAGR Net Profit
|
74.79 % | 206.06 % | 20.84 % |
|
5yr Average Return on Assets
|
8.44 % | -3.4 % | 5.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.89 % | 49.38 % | 53.5 % |
|
Share Pledged by Promoters
|
0.0 | 0.26 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -18.74 % | -16.41 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.37 % | 0.0 |
|
Aptus Pharma
|
Zota Health Care
|
Sunrest Lifescience
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|